The pathophysiology of pituitary adenomas
- 1 October 2009
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 23 (5), 525-541
- https://doi.org/10.1016/j.beem.2009.05.004
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Rat Prolactinoma Cell Growth Regulation by Epidermal Growth Factor Receptor LigandsCancer Research, 2008
- Senescence Mediates Pituitary Hypoplasia and Restrains Pituitary Tumor GrowthCancer Research, 2007
- Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an updateHuman Molecular Genetics, 2007
- Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transitionOncogene, 2007
- Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutationsProceedings of the National Academy of Sciences of the United States of America, 2007
- Germ-line mutations in p27
Kip1
cause a multiple endocrine neoplasia syndrome in rats and humansProceedings of the National Academy of Sciences of the United States of America, 2006
- Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing diseaseGenes & Development, 2006
- Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceAdvances in Enzyme Regulation, 2006
- Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and non-neoplastic astrocytesBiochemical and Biophysical Research Communications, 2005
- Low Expression of the Cell Cycle Inhibitor p27Kip1 in Normal Corticotroph Cells, Corticotroph Tumors, and Malignant Pituitary TumorsJournal of Clinical Endocrinology & Metabolism, 1999